GER-009-06-AVX Early Therapy in Multiple Sclerosis.
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2015
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms FIT
- Sponsors Biogen Idec
- 23 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jul 2007 New trial record.